Long-Term Quality of Life Following Endoscopic Therapy Compared to Esophagectomy for Neoplastic Barrett’s Esophagus

Chanakyaram A. Reddy, Anna Tavakkoli, Vincent L. Chen, Sheryl Korsnes, Aarti Oza Bedi, Philip W. Carrott, Andrew C. Chang, Kiran H. Lagisetty, Richard S. Kwon, B. Joseph Elmunzer, Mark B. Orringer, Cyrus Piraka, Anoop Prabhu, Rishindra M. Reddy, Erik Wamsteker, Joel H. Rubenstein

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Introduction: Endoscopic therapy (ET) and esophagectomy result in similar survival for Barrett’s esophagus (BE) with high-grade dysplasia (HGD) or T1a esophageal adenocarcinoma (EAC), but the long-term quality of life (QOL) has not been compared. Aims: We aimed to compare long-term QOL between patients who had undergone ET versus esophagectomy. Methods: Patients were included if they underwent ET or esophagectomy at the University of Michigan since 2000 for the treatment of HGD or T1a EAC. Two validated survey QOL questionnaires were mailed to the patients. We compared QOL between and within groups (ET = 91, esophagectomy = 62), adjusting for covariates. Results: The median time since initial intervention was 6.8 years. Compared to esophagectomy, ET patients tended to be older, had a lower prevalence of EAC, and had a shorter duration since therapy. ET patients had worse adjusted physical and role functioning than esophagectomy patients. However, the adjusted odds ratio (OR) of having symptoms was significantly less with ET for diarrhea (0.287; 95% confidence interval [CI] = 0.114, 0.724), trouble eating (0.207; 0.0766, 0.562), choking (0.325; 0.119, 0.888), coughing (0.291; 0.114, 0.746), and speech difficulty (0.306; 0.0959, 0.978). Amongst the ET patients, we found that the number of therapy sessions and need for dilation were associated with worse outcomes. Discussion: Multiple measures of symptom status were better with ET compared to esophagectomy following treatment of BE with HGD or T1a EAC. We observed worse long-term physical and role functioning in ET patients which could reflect unmeasured baseline functional status rather than a causal effect of ET.

Original languageEnglish (US)
Pages (from-to)1580-1587
Number of pages8
JournalDigestive Diseases and Sciences
Issue number5
StatePublished - May 2021


  • Endoscopic mucosal resection
  • Quality of life
  • Radiofrequency ablation

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology


Dive into the research topics of 'Long-Term Quality of Life Following Endoscopic Therapy Compared to Esophagectomy for Neoplastic Barrett’s Esophagus'. Together they form a unique fingerprint.

Cite this